After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Research leaders from OpenAI, Anthropic, and Google DeepMind are urging tech companies and research groups to monitor AI's ...

While ChatGPT emerged as the front-runner in this study, the authors caution against premature clinical adoption of any ...

Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...

Monitoring AI's train of thought is critical for improving AI safety and catching deception. But we're at risk of losing this ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

This AI system can analyze up to one million DNA letters at once, predicting how tiny changes in noncoding regions trigger ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Scientists unite to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.